Concourse Financial Group Securities’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 10630 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 10910 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 10820 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 10667 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 10689 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 10818 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 10860 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 10938 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 10558 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 10561 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 10376 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 10159 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 9916 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 9473 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 8802 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 8295 |
|